• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zydus Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Cadila
  • BSE Code : 20883.0
  • ISIN : INE010B01027
859.65 -21 (-2.34%)
  • As on 26 Apr 2025 (EOD)

  • Today’s Low

    858.00

  • Today’s High

    882.35

  • Open

    879.65

  • Perv Close

    880.25

  • 52W Low

    795.00

  • 52W High

    1,324.30

Key Indicators

  • P/E(TTM)

    19.77

  • Mar.Cap (₹Cr.)

    86,500.90

  • Div & Yield %

    0.35

  • Book Value(₹)

    177.87

  • Debt-Equity Ratio

    -2.34

  • AGM Date

    25-Apr-2025

  • EPS

    43.46

  • P/E Ratio

    19.77

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    86,500.90

  • RONW (%)

    20.64

  • ROCE (%)

    23.94

Score Board

  • Equity (₹ in Cr.)

    100.62

  • BV (₹)

    177.90

  • Sales( ₹ in Cr.)

    10,818.70

  • NP (in Cr.)

    3,437.60

  • NP Var(%)

    112.0

  • Div%

    300.0

  • CPS (₹)

    39.20

  • EPS (₹)

    34.20

  • Traded Value (₹ in Lakhs)

    86,445.56

  • 52 Week High

    1,324.30

  • 52 Week Low

    795.00

  • Price BSE

    859.0

  • Price NSE

    860.00

  • Market Capital( in Cr.)

    86,445.56

  • P/C Ratio

    21.90

  • P/E Ratio

    25.10

  • Price Vs.BV

    34.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40 6,037.40
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40 6,037.40
Other Income 1,084.80 548.40 178.70 89.30 908.70 605.20
Stock Adjustments 131.70 -105.10 46.90 148.30 -15.50 86.00
Total Income 12,035.20 9,174.90 8,062.50 8,017.60 7,240.60 6,728.60
EXPENDITURE :            
Raw Materials 3,284.60 3,066.20 2,917.10 2,499.70 1,936.20 1,950.20
Power and Fuel Cost 298.20 278.60 245.20 193.20 208.40 200.20
Employee Cost 1,507.50 1,321.90 1,204.90 1,147.30 1,077.40 961.20
Other Manufacturing Expenses 347.20 332.50 381.10 363.40 327.30 347.00
Selling and Administration Expenses 1,016.00 1,039.80 958.40 1,009.10 925.30 755.00
Miscellaneous Expenses 446.80 336.90 578.30 594.40 486.20 280.00
Employee Benefit Expenses 1,507.50 1,321.90 1,204.90 1,147.30 1,077.40 961.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,900.30 6,375.90 6,285.00 5,807.10 4,960.80 4,493.60
Operating Profit 5,134.90 2,799.00 1,777.50 2,210.50 2,279.80 2,235.00
Interest 390.70 278.20 134.90 70.90 233.90 89.60
Gross Profit 4,744.20 2,520.80 1,642.60 2,139.60 2,045.90 2,145.40
Depreciation 504.40 488.60 478.70 451.10 428.90 358.20
Profit Before Tax 4,239.80 2,032.20 1,163.90 1,688.50 1,617.00 1,787.20
Current Tax 934.30 461.80 260.20 303.30 164.10 335.40
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -136.00 41.20 45.80 -91.00 40.00 -33.90
Reported Net Profit 3,441.50 1,529.20 857.90 1,476.20 1,412.90 1,485.70
Extraordinary Items 3.90 -92.27 -237.64 -156.95 -52.67 74.44
Adjusted Net Profit 3,437.60 1,621.47 1,095.54 1,633.15 1,465.57 1,411.26
Adjustment below Net Profit -54.00 1.80 -6.90 -15.30 -6.00 -294.40
P & L Balance brought forward 10,567.40 9,289.40 8,796.90 7,336.00 6,645.70 5,812.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 607.30 253.00 358.50 0.00 716.60 358.30
P & L Balance carried down 13,347.60 10,567.40 9,289.40 8,796.90 7,336.00 6,645.70
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 300.00 600.00 250.00 350.00 350.00 350.00
Dividend Per Share(Rs) 3.00 6.00 2.50 3.50 3.50 3.50
Earnings Per Share-Unit Curr 34.21 15.11 8.38 14.42 13.80 14.51
Earnings Per Share(Adj)-Unit Curr 34.21 15.11 8.38 14.42 13.80 14.51
Book Value 156.23 134.78 129.30 124.46 109.96 83.68
Book Value(Adj)-Unit Curr 156.23 134.78 129.30 124.46 109.96 83.68

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,730 0.00 17,730 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 278,466 0.03 278,466 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 754,328,118 74.97 754,328,118 2
Others 0 0.00 0 0
Sub Total 754,624,314 74.99 754,624,314 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 15,785 0.00 15,785 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 165,100 0.02 162,790 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 73,610,460 7.32 73,610,460 628
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 44,113,082 4.38 44,113,082 16
Mutual Funds / UTI 64,011,609 6.36 64,011,609 28
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,459,677 0.24 2,459,677 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 184,375,713 18.32 184,373,403 698
2] Non Institution
Bodies Corporate 5,609,469 0.56 5,609,469 984
Clearing Members 1,481 0.00 1,481 10
Directors of their Relatives 372,464 0.04 372,464 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,003,567 0.30 2,996,742 7,842
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,489,057 0.15 1,488,307 4,174
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,629,237 0.76 7,629,237 7
Individuals holding nominal share capital up to Rs. 1 lakh 46,774,657 4.65 45,412,257 357,767
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 209,825 0.02 209,825 21
Others 1,690,879 0.17 1,690,879 2
Sub Total 67,233,963 6.68 65,863,988 370,909
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 1,006,233,990 100.00 1,004,861,705 371,619

Company Background

Zydus Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zydus Lifesciences Ltd
  • BSE Code : 20883.0
  • ISIN : INE010B01027

  • Incorporation Year

    1995

  • Registered Office

    Zydus Corporate Park S No 536
    Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad,
    Gujarat-382481

  • Telephone

    91-079-26868100

  • FAX

    91-079-26868337/26862365/26862366

  • Chairman

    Pankaj R Patel

  • Managing Director

    Sharvil P Patel

  • Company Secretary

    Dhaval N Soni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Zydus Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zydus Lifesci. 859.10 11,903.50 10,818.70 19.80 22.73
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92